Streetwise Nutraceuticals Sponsors
Select a name to see a detailed description, expert analysis and contact information.
|"On a site visit, we were impressed with GFG, the location and access."|
|"INO's pro forma cash position after the offering could be around $160M and should be sufficient for 18 months of operations; we reiterate our Buy rating."|
|"NXE released assay results; of special interest is the first uranium mineralization hit on the parallel structure south of Arrow."|
|"VIT's Eagle is a low-cost, lower-risk project with permits in hand."|
|"EFR's profit margins remained strong at 30% in H1/17."|